Department of Neuroscience of Disease,
Center for Transdisciplinary Research,
Brain Research Institute,
Department of Neuroscience of Disease, Center for Transdisciplinary Research
Hideaki Matsui has not added Biography.
If you are Hideaki Matsui and would like to personalize this page please email our Author Liaison for assistance.
[Two cases of Parkinson's disease in which visual hallucinations disappeared after cataract surgery].
No to shinkei = Brain and nerve Apr, 2004 | Pubmed ID: 15237728
POEMS syndrome demonstrating VEGF decrease by ticlopidine.
Internal medicine (Tokyo, Japan) Nov, 2004 | Pubmed ID: 15609708
The relation between visual hallucinations and visual evoked potential in Parkinson disease.
Clinical neuropharmacology Mar-Apr, 2005 | Pubmed ID: 15795550
Brain perfusion differences between Parkinson's disease and multiple system atrophy with predominant parkinsonian features.
Parkinsonism & related disorders Jun, 2005 | Pubmed ID: 15878583
Metaiodobenzylguanidine (MIBG) scintigraphy at various parts of the body in Parkinson's disease and multiple system atrophy.
Autonomic neuroscience : basic & clinical Apr, 2005 | Pubmed ID: 15893708
Persistent primitive hypoglossal artery with atrial septal defect.
Internal medicine (Tokyo, Japan) May, 2005 | Pubmed ID: 15942106
Metaiodobenzylguanidine (MIBG) uptake in Parkinson's disease also decreases at thyroid.
Annals of nuclear medicine May, 2005 | Pubmed ID: 15981676
Three-dimensional stereotactic surface projection study of freezing of gait and brain perfusion image in Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society Oct, 2005 | Pubmed ID: 16007622
Multiple sclerosis following splenectomy as a treatment for idiopathic thrombocytopenic purpura.
Internal medicine (Tokyo, Japan) Jul, 2005 | Pubmed ID: 16093599
Biferrocene-M(mnt)2 charge-transfer complexes (M = Ni, Co; mnt = maleonitriledithiolate). structure, valence states, and magnetic properties.
Inorganic chemistry Nov, 2005 | Pubmed ID: 16271005
N-isopropyl-p- 123I iodoamphetamine single photon emission computed tomography study of Parkinson's disease with dementia.
Internal medicine (Tokyo, Japan) Oct, 2005 | Pubmed ID: 16293914
Impaired visual acuity as a risk factor for visual hallucinations in Parkinson's disease.
Journal of geriatric psychiatry and neurology Mar, 2006 | Pubmed ID: 16449759
Frontal assessment battery and brain perfusion image in Parkinson's disease.
Journal of geriatric psychiatry and neurology Mar, 2006 | Pubmed ID: 16449760
Parkinson's disease following panic disorder.
The Journal of neuropsychiatry and clinical neurosciences , 2006 | Pubmed ID: 16525084
HTLV-I-associated peripheral neuropathy with smoldering-type adult T-cell leukemia.
The neurologist Mar, 2006 | Pubmed ID: 16534449
Does cardiac metaiodobenzylguanidine (MIBG) uptake in Parkinson's disease correlate with major autonomic symptoms?
Parkinsonism & related disorders Jun, 2006 | Pubmed ID: 16549383
Wisconsin Card Sorting Test and brain perfusion imaging in Parkinson's disease.
Parkinsonism & related disorders Jun, 2006 | Pubmed ID: 16551505
Disruptions of the fornix fiber in Parkinsonian patients with excessive daytime sleepiness.
Parkinsonism & related disorders Jun, 2006 | Pubmed ID: 16621664
Encephalopathy and severe neuropathy due to probable systemic vasculitis as an initial manifestation of mixed connective tissue disease.
Neurology India Mar, 2006 | Pubmed ID: 16679652
Minor depression and brain perfusion images in Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society Aug, 2006 | Pubmed ID: 16685687
Excessive daytime sleepiness in Parkinson disease: a SPECT study.
Sleep Jul, 2006 | Pubmed ID: 16895259
Hypoperfusion of the auditory and prefrontal cortices in Parkinsonian patients with verbal hallucinations.
Movement disorders : official journal of the Movement Disorder Society Dec, 2006 | Pubmed ID: 17029260
Hypoperfusion of the visual pathway in parkinsonian patients with visual hallucinations.
Movement disorders : official journal of the Movement Disorder Society Dec, 2006 | Pubmed ID: 17029272
Adult onset hemiparkinsonism with brain hemihypoplasia.
Neurology India Dec, 2006 | Pubmed ID: 17114871
Heterogeneous factors in dementia with Parkinson's disease: IMP-SPECT study.
Parkinsonism & related disorders Apr, 2007 | Pubmed ID: 17145197
Auditory event-related potentials in Parkinson's disease: prominent correlation with attention.
Parkinsonism & related disorders Oct, 2007 | Pubmed ID: 17329143
Trousseau syndrome due to pleural mesothelioma.
The neurologist Jul, 2007 | Pubmed ID: 17622912
Depression in Parkinson's disease. Diffusion tensor imaging study.
Journal of neurology Sep, 2007 | Pubmed ID: 17710361
Thalamic hyperperfusion in verbal hallucination of Parkinsonian patients.
Internal medicine (Tokyo, Japan) , 2007 | Pubmed ID: 17978532
[Pathological mechanisms of Parkinson's disease].
Brain and nerve = Shinkei kenkyu no shinpo Apr, 2009 | Pubmed ID: 19378814
A chemical neurotoxin, MPTP induces Parkinson's disease like phenotype, movement disorders and persistent loss of dopamine neurons in medaka fish.
Neuroscience research Nov, 2009 | Pubmed ID: 19665499
Loss of PINK1 in medaka fish (Oryzias latipes) causes late-onset decrease in spontaneous movement.
Neuroscience research Feb, 2010 | Pubmed ID: 19895857
Proteasome inhibition in medaka brain induces the features of Parkinson's disease.
Journal of neurochemistry Oct, 2010 | Pubmed ID: 20649841
Ammonium chloride and tunicamycin are novel toxins for dopaminergic neurons and induce Parkinson's disease-like phenotypes in medaka fish.
Journal of neurochemistry Dec, 2010 | Pubmed ID: 21219329
[An investigation on prognostic diagnosis and therapeutic effects for peripheral facial nerve palsy].
Masui. The Japanese journal of anesthesiology Mar, 2012 | Pubmed ID: 22571125
Medaka fish Parkinson's disease model.
Experimental neurobiology Sep, 2012 | Pubmed ID: 23055787
PINK1 and Parkin complementarily protect dopaminergic neurons in vertebrates.
Human molecular genetics Jun, 2013 | Pubmed ID: 23449626
ATP13A2 deficiency induces a decrease in cathepsin D activity, fingerprint-like inclusion body formation, and selective degeneration of dopaminergic neurons.
FEBS letters May, 2013 | Pubmed ID: 23499937
TigarB causes mitochondrial dysfunction and neuronal loss in PINK1 deficiency.
Annals of neurology Dec, 2013 | Pubmed ID: 24027110
Exploring the pathogenetic mechanisms underlying Parkinson's disease in medaka fish.
Journal of Parkinson's disease , 2014 | Pubmed ID: 24366926
Functional regionalization of the teleost cerebellum analyzed in vivo.
Proceedings of the National Academy of Sciences of the United States of America Aug, 2014 | Pubmed ID: 25002482
Viable neuronopathic Gaucher disease model in Medaka (Oryzias latipes) displays axonal accumulation of alpha-synuclein.
PLoS genetics Apr, 2015 | Pubmed ID: 25835295
Zebrafish jam-b2 Gal4-enhancer trap line recapitulates endogenous jam-b2 expression in extraocular muscles.
Developmental dynamics : an official publication of the American Association of Anatomists Dec, 2015 | Pubmed ID: 26370768
[Difficult Airway Management of a Patient with the Ossification of Anterior Longitudinal Ligament].
Masui. The Japanese journal of anesthesiology Apr, 2015 | Pubmed ID: 26419102
Identification of the zebrafish red nucleus using Wheat Germ Agglutinin transneuronal tracing.
Communicative & integrative biology Dec, 2014 | Pubmed ID: 26480025
Large enhancement of superconducting transition temperature in single-element superconducting rhenium by shear strain.
Scientific reports Nov, 2016 | Pubmed ID: 27811983
Atsushi Sugie1,2,5,
Christoph Möhl3,
Satoko Hakeda-Suzuki4,
Hideaki Matsui1,2,
Takashi Suzuki*,4,
Gaia Tavosanis*,5
1Department of Neuroscience of Disease, Center for Transdisciplinary Research, Niigata University,
2Brain Research Institute, Niigata University,
3Image and Data Analysis Facility, German Center for Neurodegenerative Diseases (DZNE),
4Graduate School of Life Science and Technology, Tokyo Institute of Technology (Titech),
5Dendrite Differentiation, German Center for Neurodegenerative Diseases (DZNE)
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved